Stocktoria
Absci Corp ABSI
Nasdaq · XNAS · stock · Services-Commercial Physical & Biological Research · website · IPO 2021-07-22
Absci Corp statistics & valuation
Market cap$1.7B
P / B9.0×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -4297.0% | -2401.6% | -2020.2% | -1857.5% | -1573.4% |
| Net margin | -4113.7% | -2274.1% | -1933.6% | -1825.4% | -2111.3% |
| FCF margin | -3358.3% | -1605.8% | -1145.4% | -1696.8% | -2062.8% |
| Return on assets | -53.3% | -48.3% | -50.9% | -32.7% | -23.7% |
| Return on equity | -60.8% | -57.6% | -62.8% | -38.2% | -27.6% |
| Debt / equity | — | 0.02× | 0.04× | 0.04× | 0.01× |
| Current ratio | 6.57 | 4.67 | 4.08 | 6.17 | 8.07 |
| Revenue growth | -38.2% | -20.7% | -0.5% | 20.2% | 0.0% |
Source: SEC EDGAR filings · CIK 0001672688 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.